Provided herein are pharmaceutical compositions and methods useful for treating cancer and preventing cancer metastasis, particularly in cancers that have increased MDA-9/Syntenin expression.

The present invention relates to the use of compounds in the treatment of autoimmune conditions, and in particular, for the treatment of rheumatoid arthritis.

The present invention relates to the use of compounds in the treatment of autoimmune conditions, and in particular, for the treatment of rheumatoid arthritis.

The present invention relates to the use of compounds in the treatment of a viral infection, wherein the virus is selected from the Orthomyxoviridae family or wherein the virus is West Nile virus.

The present invention relates to the use of compounds in the treatment of a viral infection, wherein the virus is selected from the Orthomyxoviridae family or wherein the virus is West Nile virus.

The present invention relates to the use of compounds in the treatment of a viral infection, wherein the virus is selected from the Orthomyxoviridae family or wherein the virus is West Nile virus.

A compound of general formula (I) wherein X, Y, n, p, q, and R.sub.1-R.sub.17 take various meanings, for use in the treatment of Coronavirus infection.

##STR00001##

A compound of general formula (I) wherein X, Y, n, p, q, and R.sub.1-R.sub.17 take various meanings, for use in the treatment of Coronavirus infection.

##STR00001##

A compound of general formula (I) wherein X, Y, n, p, q, and R.sub.1-R.sub.17 take various meanings, for use in the treatment of Coronavirus infection.

##STR00001##

The use of PLD with one or more further CoV antiviral agent(s) in the treatment of coronavirus (CoV) infection.